(R)-N-(4-(2-(2-hydroxy-2-(pyridin-3-yl)ethylamino)ethyl)phenyl)-2-(pyrrolidin-1-yl)benzamide

ID: ALA1089735

PubChem CID: 46881902

Max Phase: Preclinical

Molecular Formula: C26H30N4O2

Molecular Weight: 430.55

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1)c1ccccc1N1CCCC1

Standard InChI:  InChI=1S/C26H30N4O2/c31-25(21-6-5-14-27-18-21)19-28-15-13-20-9-11-22(12-10-20)29-26(32)23-7-1-2-8-24(23)30-16-3-4-17-30/h1-2,5-12,14,18,25,28,31H,3-4,13,15-17,19H2,(H,29,32)/t25-/m0/s1

Standard InChI Key:  OAFWFJPMALLJIG-VWLOTQADSA-N

Molfile:  

     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
   10.1819  -20.7583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1807  -21.5857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8956  -21.9985    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.6120  -21.5852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6091  -20.7547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8938  -20.3455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3221  -20.3395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0381  -20.7493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3189  -19.5145    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.7510  -20.3341    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.4670  -20.7439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1799  -20.3287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8959  -20.7385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8962  -21.5636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6113  -21.9733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3252  -21.5581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3195  -20.7288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6037  -20.3228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0418  -21.9669    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.7542  -21.5508    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7500  -20.7258    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.4707  -21.9596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4723  -22.7844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1880  -23.1932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9013  -22.7770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8944  -21.9478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1782  -21.5427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1708  -20.7177    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.8295  -20.2286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5675  -19.4463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7425  -19.4537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4947  -20.2406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 15 16  2  0
  7  8  1  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
  7  9  1  1
 16 19  1  0
  4  5  1  0
 19 20  1  0
  8 10  1  0
 20 21  2  0
  2  3  1  0
 20 22  1  0
 10 11  1  0
 22 23  2  0
  5  6  2  0
 23 24  1  0
 11 12  1  0
 24 25  2  0
  6  1  1  0
 25 26  1  0
 12 13  1  0
 26 27  2  0
 27 22  1  0
  1  2  2  0
 27 28  1  0
 28 29  1  0
 13 14  2  0
  5  7  1  0
 14 15  1  0
  3  4  2  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 28  1  0
M  END

Associated Targets(Human)

ADRB3 Tclin Beta-3 adrenergic receptor (5850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 430.55Molecular Weight (Monoisotopic): 430.2369AlogP: 3.80#Rotatable Bonds: 9
Polar Surface Area: 77.49Molecular Species: BASEHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 13.87CX Basic pKa: 9.45CX LogP: 3.30CX LogD: 1.27
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.45Np Likeness Score: -1.29

References

1. Goble SD, Wang L, Howell KL, Bansal A, Berger R, Brockunier L, DiSalvo J, Feighner S, Harper B, He J, Hurley A, Hreniuk D, Parmee E, Robbins M, Salituro G, Sanfiz A, Streckfuss E, Watkins E, Weber AE, Struthers M, Edmondson SD..  (2010)  Heterocyclic acetamide and benzamide derivatives as potent and selective beta3-adrenergic receptor agonists with improved rodent pharmacokinetic profiles.,  20  (6): [PMID:20181479] [10.1016/j.bmcl.2010.01.130]

Source